Cancer Registry Software Market Revenue 2025 to 2034

Cancer Registry Software Market Revenue 2025 to 2034

Cancer Registry Software Market(By Software: Cross-disciplinary, Specific; By Deployment Model: On-premise, Cloud-based; By Component: Commercial, Public; By End Use: Government & Third Party, Private Payers, Hospitals & Medical Practices, Pharma, Biotech & Medical Device Companies, Research Institutes; By Functionality: Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research & Clinical Studies; By Geography: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) – Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Report ID: 10922 | Format: Databook | Published: December 2025 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue, 2025

USD 94.68 Bn

Forecast Year, 2034

USD 273.29 Bn

CAGR, 2025 - 2034

12.50%

Report Coverage

Worldwide

Published By

Saurabh Bidwai

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

The global cancer registry software market is expanding steadily, driven by rising cancer incidence and the need for accurate data management. Market growth is supported by digital healthcare adoption and demand for advanced analytics across healthcare systems worldwide.

Cancer Registry Software Market Size Analysis

Cancer Registry Software Market Size By Software 2025 to 2034 (USD Million)

Software 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Cross disciplinary52.0757.7664.0471.0078.6987.2196.61107.01118.50131.18
Specific42.6148.7655.7963.8172.9783.4195.33108.93124.43142.11

Cancer Registry Software Market Size By Deployment Model 2025 to 2034 (USD Million)

Deployment Model 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
On-premise56.8161.7867.1072.8078.8685.3192.1399.33106.89114.78
Cloud-based37.8744.7452.7362.0172.8085.3199.81116.61136.04158.51

Cancer Registry Software Market Size By Component 2025 to 2034 (USD Million)

Component 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Commercial61.5469.8379.2289.87101.95115.64131.16148.76168.70191.30
Public33.1436.6940.6144.9449.7154.9860.7867.1874.2381.99

Cancer Registry Software Market Size By End Use 2025 to 2034 (USD Million)

End Use 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Government and third party28.4031.4834.8838.6542.8047.3952.4658.0664.2471.06
Private payers17.0419.4122.1025.1628.6532.6137.1142.2348.0554.66
Hospital and medical practice23.6726.8730.4934.6039.2644.5550.5457.3465.0573.79
Pharma biotech and medical device companies16.1018.3520.9023.8227.1330.9035.1940.0745.6251.93
Research institutes9.4710.4211.4512.5813.8215.1716.6318.2319.9721.86

Cancer Registry Software Market Size By Functionality 2025 to 2034 (USD Million)

Functionality 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Cancer Reporting to Meet State & Federal Regulations30.3033.6137.2841.3445.8450.8156.3062.3869.1076.52
Patient Care Management23.6726.8730.4934.6039.2644.5550.5457.3465.0573.79
Product Outcome Evaluation17.0419.4122.1025.1628.6532.6137.1142.2348.0554.66
Medical Research and Clinical Studies23.6726.6329.9633.7037.9242.6647.9853.9860.7368.32

Cancer Registry Software Market Size By Geography 2025 to 2034 (USD Million)

Geography 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America35.9840.0044.4749.4354.9361.0467.8275.3483.6892.92
Europe25.5628.5231.8235.5039.6044.1749.2654.9461.2768.32
Asia-Pacific20.8324.1427.9632.3537.4143.2249.9057.5866.4076.52
Latin America7.578.649.8511.2312.8114.6016.6318.9521.5924.60
Middle East & Africa (MEA)4.735.215.736.296.917.588.329.129.9910.93

Cancer Registry Software Market Size to Reach USD 273.29 Million by 2034

The global cancer registry software market size was estimated at USD 94.68 million in 2025 and is projected to be worth around USD 273.29 billion by 2034 with a CAGR of 12.50%

Our Client